You are currently viewing the editor's summary.
View Full TextLog in to view the full text
AAAS login provides access to Science for AAAS members, and access to other journals in the Science family to users who have purchased individual subscriptions.
Register for free to read this article
As a service to the community, this article is available for free. Existing users log in.
More options
Download and print this article for your personal scholarly, research, and educational use.
Buy a single issue of Science for just $15 USD.
Restoring Hematopoietic Function
Hematopoietic stem cell (HSC) function decreases with age, a process that likely contributes to the weakened adaptive immune response characteristic of older individuals. Chen et al. found that HSCs from old mice showed increased activation of mammalian target of rapamycin (mTOR) signaling compared to those from young mice. Intriguingly, inhibition of mTOR with the drug rapamycin reversed aging-related declines in mouse HSC function and enhanced the ability of old mice to mount an effective immune response to infection with influenza virus. The authors thus propose that manipulation of mTOR signaling may lead to therapeutic approaches to restoring aging-related declines in HSC function.
